QUANTA SVCS DL-,00001/ US74762E1029 /
| 2024-05-13 10:11:34 PM | Chg. -6.70 | Volume | Bid10:11:34 PM | Ask10:11:34 PM | Market Capitalization | Dividend Y. | P/E Ratio |
|---|---|---|---|---|---|---|---|
| 244.20EUR | -2.67% | - Turnover: - |
244.20Bid Size: - | 248.10Ask Size: - | 36.15 bill.EUR | - | - |
GlobeNewswire
10:10 PM
Centessa Pharmaceuticals Reports Financial Results and Business Highlights for the First Quarter of ...
GlobeNewswire
10:05 PM
Infinera Corporation Fourth Quarter and Fiscal 2023 Summary of Key Financial Results
GlobeNewswire
10:05 PM
NEXGEL Reports First Quarter 2024 Revenue of $1.27 Million, an Increase of 104% Year-Over-Year
GlobeNewswire
10:05 PM
Kandi Technologies to Report First Quarter 2024 Financial Results and Hold a Conference Call on May ...
GlobeNewswire
10:05 PM
CompoSecure Chief Product & Innovation Officer to Speak at Seamless Middle East 2024
GlobeNewswire
10:05 PM
Helius Medical Technologies, Inc. Reports First Quarter 2024 Financial Results
GlobeNewswire
10:05 PM
Capricor Therapeutics Reports First Quarter 2024 Financial Results and Provides Corporate Update
GlobeNewswire
10:05 PM
scPharmaceuticals to Present at the H.C. Wainwright 2nd Annual BioConnect Investor Conference
GlobeNewswire
10:05 PM
Generation Bio Announces Recent Business Highlights and First Quarter 2024 Financial Results
GlobeNewswire
10:05 PM
Banzai Continues Strong Organic Growth with the Addition of Over 230 Customers in April
GlobeNewswire
10:05 PM
180 Degree Capital Corp. Reports Net Asset Value per Share (“NAV”) of $5.16 as of March 31, 2024
GlobeNewswire
10:05 PM
RxSight, Inc. Announces Closing of its Public Offering of Common Stock and Full Exercise of Underwri...
GlobeNewswire
10:05 PM
iBio Reports Fiscal Third Quarter 2024 Financial Results and Provides Corporate Update
